Efficacy of amlodipine in the treatment of stable effort angina. An echocardiographic stress study

Carmine Dario Vizza, Susanna Sciomer, Anna Giustini, Alessandra Dagianti, Francesco Fedele, Armando Dagianti

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The purpose of this double-blind placebo-controlled crossover study was to assess the antianginal efficacy of oral amlodipine (10 mg once daily) in 16 patients with stable effort angina. After each 7-day treatment period, patients underwent symptom-limited exercise tests with electrocardiographic and 2D-echocardiographic assessment. Under resting conditions, systolic arterial pressure was significantly lower after treatment with amlodipine compared with placebo (126.5 vs 132.8 mm Hg). Heart rate and the pressure-rate product did not differ appreciably between amlodipine and placebo treatment. The stress test results showed an increase in effort tolerance during amlodipine treatment compared with placebo (time to onset of angina = 6.8 vs 5.7 min), with a negative test in 25% of patients (4 of 16). These favourable effects may be attributed to a reduction in myocardial oxygen consumption, as indicated by a slower increase in systolic blood pressure during exercise and the delayed occurrence of ischaemia during amlodipine therapy (time to ST-segment depression of 1 mm = 4.5 vs 3.5 minutes). Moreover, the fact that patients with negative tests during amlodipine were able to work above their ischaemic threshold during placebo, suggests a possible increase in myocardial blood flow with amlodipine. In conclusion, amlodipine is effective in the treatment of stable angina pectoris. This drug reduces myocardial oxygen consumption and, in some patients, may also increase myocardial blood flow.

Original languageEnglish
Pages (from-to)108-112
Number of pages5
JournalClinical Drug Investigation
Volume13
Issue numberSUPPL. 1
Publication statusPublished - 1997

Fingerprint

Amlodipine
Stable Angina
Placebos
Therapeutics
Blood Pressure
Exercise Test
Oxygen Consumption
Cross-Over Studies
Arterial Pressure
Ischemia
Heart Rate
Exercise
Pressure

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Vizza, C. D., Sciomer, S., Giustini, A., Dagianti, A., Fedele, F., & Dagianti, A. (1997). Efficacy of amlodipine in the treatment of stable effort angina. An echocardiographic stress study. Clinical Drug Investigation, 13(SUPPL. 1), 108-112.

Efficacy of amlodipine in the treatment of stable effort angina. An echocardiographic stress study. / Vizza, Carmine Dario; Sciomer, Susanna; Giustini, Anna; Dagianti, Alessandra; Fedele, Francesco; Dagianti, Armando.

In: Clinical Drug Investigation, Vol. 13, No. SUPPL. 1, 1997, p. 108-112.

Research output: Contribution to journalArticle

Vizza, CD, Sciomer, S, Giustini, A, Dagianti, A, Fedele, F & Dagianti, A 1997, 'Efficacy of amlodipine in the treatment of stable effort angina. An echocardiographic stress study', Clinical Drug Investigation, vol. 13, no. SUPPL. 1, pp. 108-112.
Vizza CD, Sciomer S, Giustini A, Dagianti A, Fedele F, Dagianti A. Efficacy of amlodipine in the treatment of stable effort angina. An echocardiographic stress study. Clinical Drug Investigation. 1997;13(SUPPL. 1):108-112.
Vizza, Carmine Dario ; Sciomer, Susanna ; Giustini, Anna ; Dagianti, Alessandra ; Fedele, Francesco ; Dagianti, Armando. / Efficacy of amlodipine in the treatment of stable effort angina. An echocardiographic stress study. In: Clinical Drug Investigation. 1997 ; Vol. 13, No. SUPPL. 1. pp. 108-112.
@article{5c91325ec52a48b99f1fa22bb2817104,
title = "Efficacy of amlodipine in the treatment of stable effort angina. An echocardiographic stress study",
abstract = "The purpose of this double-blind placebo-controlled crossover study was to assess the antianginal efficacy of oral amlodipine (10 mg once daily) in 16 patients with stable effort angina. After each 7-day treatment period, patients underwent symptom-limited exercise tests with electrocardiographic and 2D-echocardiographic assessment. Under resting conditions, systolic arterial pressure was significantly lower after treatment with amlodipine compared with placebo (126.5 vs 132.8 mm Hg). Heart rate and the pressure-rate product did not differ appreciably between amlodipine and placebo treatment. The stress test results showed an increase in effort tolerance during amlodipine treatment compared with placebo (time to onset of angina = 6.8 vs 5.7 min), with a negative test in 25{\%} of patients (4 of 16). These favourable effects may be attributed to a reduction in myocardial oxygen consumption, as indicated by a slower increase in systolic blood pressure during exercise and the delayed occurrence of ischaemia during amlodipine therapy (time to ST-segment depression of 1 mm = 4.5 vs 3.5 minutes). Moreover, the fact that patients with negative tests during amlodipine were able to work above their ischaemic threshold during placebo, suggests a possible increase in myocardial blood flow with amlodipine. In conclusion, amlodipine is effective in the treatment of stable angina pectoris. This drug reduces myocardial oxygen consumption and, in some patients, may also increase myocardial blood flow.",
author = "Vizza, {Carmine Dario} and Susanna Sciomer and Anna Giustini and Alessandra Dagianti and Francesco Fedele and Armando Dagianti",
year = "1997",
language = "English",
volume = "13",
pages = "108--112",
journal = "Clinical Drug Investigation",
issn = "1173-2563",
publisher = "Adis International Ltd",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Efficacy of amlodipine in the treatment of stable effort angina. An echocardiographic stress study

AU - Vizza, Carmine Dario

AU - Sciomer, Susanna

AU - Giustini, Anna

AU - Dagianti, Alessandra

AU - Fedele, Francesco

AU - Dagianti, Armando

PY - 1997

Y1 - 1997

N2 - The purpose of this double-blind placebo-controlled crossover study was to assess the antianginal efficacy of oral amlodipine (10 mg once daily) in 16 patients with stable effort angina. After each 7-day treatment period, patients underwent symptom-limited exercise tests with electrocardiographic and 2D-echocardiographic assessment. Under resting conditions, systolic arterial pressure was significantly lower after treatment with amlodipine compared with placebo (126.5 vs 132.8 mm Hg). Heart rate and the pressure-rate product did not differ appreciably between amlodipine and placebo treatment. The stress test results showed an increase in effort tolerance during amlodipine treatment compared with placebo (time to onset of angina = 6.8 vs 5.7 min), with a negative test in 25% of patients (4 of 16). These favourable effects may be attributed to a reduction in myocardial oxygen consumption, as indicated by a slower increase in systolic blood pressure during exercise and the delayed occurrence of ischaemia during amlodipine therapy (time to ST-segment depression of 1 mm = 4.5 vs 3.5 minutes). Moreover, the fact that patients with negative tests during amlodipine were able to work above their ischaemic threshold during placebo, suggests a possible increase in myocardial blood flow with amlodipine. In conclusion, amlodipine is effective in the treatment of stable angina pectoris. This drug reduces myocardial oxygen consumption and, in some patients, may also increase myocardial blood flow.

AB - The purpose of this double-blind placebo-controlled crossover study was to assess the antianginal efficacy of oral amlodipine (10 mg once daily) in 16 patients with stable effort angina. After each 7-day treatment period, patients underwent symptom-limited exercise tests with electrocardiographic and 2D-echocardiographic assessment. Under resting conditions, systolic arterial pressure was significantly lower after treatment with amlodipine compared with placebo (126.5 vs 132.8 mm Hg). Heart rate and the pressure-rate product did not differ appreciably between amlodipine and placebo treatment. The stress test results showed an increase in effort tolerance during amlodipine treatment compared with placebo (time to onset of angina = 6.8 vs 5.7 min), with a negative test in 25% of patients (4 of 16). These favourable effects may be attributed to a reduction in myocardial oxygen consumption, as indicated by a slower increase in systolic blood pressure during exercise and the delayed occurrence of ischaemia during amlodipine therapy (time to ST-segment depression of 1 mm = 4.5 vs 3.5 minutes). Moreover, the fact that patients with negative tests during amlodipine were able to work above their ischaemic threshold during placebo, suggests a possible increase in myocardial blood flow with amlodipine. In conclusion, amlodipine is effective in the treatment of stable angina pectoris. This drug reduces myocardial oxygen consumption and, in some patients, may also increase myocardial blood flow.

UR - http://www.scopus.com/inward/record.url?scp=0030757983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030757983&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 108

EP - 112

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

SN - 1173-2563

IS - SUPPL. 1

ER -